Bengal Physician Journal

Register      Login

VOLUME 8 , ISSUE 2 ( May-August, 2021 ) > List of Articles

Original Article

A Descriptive Study of Clinicoradiological and Serum Biomarker Profile in Patients Who Died due to COVID-19 Infection in a Tertiary Care Hospital

Saikat Banerjee, Amitava Pal, Priyanka Ghosh, Subhasis Mukherjee, Supriya Sarkar

Keywords : COVID-19, Mortality, National Early Warning Score, Serum inflammatory markers

Citation Information : Banerjee S, Pal A, Ghosh P, Mukherjee S, Sarkar S. A Descriptive Study of Clinicoradiological and Serum Biomarker Profile in Patients Who Died due to COVID-19 Infection in a Tertiary Care Hospital. Bengal Physician Journal 2021; 8 (2):38-44.

DOI: 10.5005/jp-journals-10070-7052

License: CC BY-NC 4.0

Published Online: 19-09-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: The coronavirus infectious disease-2019 (COVID-19) infectivity and death rates are steadily falling as we reach the declining phase of the second wave. However, there is still no surety as to when we will be finally free from the pandemic and mortality will always remain the most important factor of concern. Materials and methods: One hundred patients who died due to COVID-19 were sampled using systematic random sampling from our hospital, and demographic, clinical, blood, and radiological investigations data were collected retrospectively. An analysis of these parameters was then done using descriptive statistical methods to point out potential risk factors for mortality, which may help in formulating future hypotheses. Results: The mean age was 68.3 years, and 69% were more than 65 years of age. Sixty-one percent were males, suggesting a male preponderance. Diabetes and hypertension were the most common comorbidities. Oxygen saturation <90%, respiratory rate >24/minute, heart rate >90/minute, impaired level of consciousness, National Early Warning Score (NEWS) >12 seem to be important mortality predictors. Neutrophil/lymphocyte ratio of more than 5.2, lymphopenia, low platelet counts, low serum albumin, electrolyte disturbances, high creatinine levels, and high serum inflammatory biomarker levels all appear to contribute to mortality in COVID-19 patients. Conclusions: More studies need to be performed to test for the variety of hypotheses proposed in this study. Early identification of these mortality indicators may help us reduce mortality in such cases by timely and appropriate intervention.


PDF Share
  1. WHO. WHO coronavirus (COVID-19) dashboard. 2021. Available from: https://covid19.who.int/.
  2. Jain AC, Kansal S, Raman S, et al. A retrospective observational study to determine the early predictors of in-hospital mortality at admission with COVID-19. Indian J Crit Care Med 2020;24(12):1174–1179. DOI: 10.5005/jp-journals-10071-23683.
  3. Suresh S, Tiwari A, Mathew R, et al. Predictors of mortality and the need of mechanical ventilation in confirmed COVID-19 patients presenting to the emergency department in North India. J Family Med Prim Care 2021;10:542–549. DOI: 10.4103/jfmpc.jfmpc_1775_20.
  4. Kansara N, Nandapurkar AB, Maniyar R, et al. Prediction of mortality by age and multi-morbidities among confirmed COVID-19 patients: secondary analysis of surveillance data in Pune, Maharashtra, India. Indian J Public Health 2021;65:64–66. DOI: 10.4103/ijph.IJPH_1096_20.
  5. Mahendra M, Nuchin A, Kumar R, et al. Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study. Adv Respir Med 2021;89(2):135–144. DOI: 10.5603/ARM.a2021.0036.
  6. Dhikale PT, Chavhan SS, Adsul BB, et al. Predictors for mortality of inpatients of COVID-19 in Mumbai. Int J Commun Med Public Health 2021;8(6):3079–3083. DOI: 10.18203/2394-6040.ijcmph20212019.
  7. Myrstad M, Ihle-Hansen H, Tveita AA, et al. National Early Warning Score 2 (NEWS2) onadmission predicts severe disease and in-hospital mortality from Covid-19 – aprospective cohort study. Scand J Trauma Resusc Emerg Med 2020;28:66. DOI: 10.1186/s13049-020-00764-3.
  8. Simadibrata DM, Calvin J, Wijaya AD, et al. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: a meta-analysis. Am J Emerg Med 2021;42:60–69. DOI: 10.1016/j.ajem.2021.01.006.
  9. Zhu B, Feng X, Jiang C, et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study. BMC Infect Dis 2021;21(1):574. DOI: 10.1186/s12879-021-06277-3.
  10. Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology 2020;88:15–27. DOI: 10.1159/000512007.
  11. Xu W, Huan C, Fei L, et al. Dynamic changes in liver function tests and their correlation with illness severity and mortality in patients with COVID-19: a retrospective cohort study. Clin Interv Aging 2021;16:675–685. DOI: 10.2147/CIA.S303629.
  12. Ding Zy, Li Gx, Chen L, et al. Association of liver abnormalities with in-hospital mortality inpatients with COVID-19. J Hepatol 2020;74:1295–1302. DOI: 10.1016/j.jhep.2020.12.012.
  13. Trabulus S, Karaca C, Balkan II, et al. Kidney function on admission predicts in-hospital mortality in COVID-19. PLoS One 2020;15(9):e0238680. DOI: 10.1371/journal.pone.0238680.
  14. Pourfridoni M, Abbasnia SM, Shafaei F, et al. Fluid and electrolyte disturbances in COVID-19 and their complications. BioMed Res Int 2021;9. DOI: 10.1155/2021/6667047.
  15. Archana B, Shyamsunder S, Das R. Validity of markers and indexes of systemic inflammation in predicting mortality in COVID 19 infection: a hospital based cross sectional study. BMJ Yale 2021. DOI: 10.1101/2021.03.30.21254635.
  16. Nadeem R, Elhoufi AM, Iqbal NE, et al. Prediction of cytokine storm and mortality in patients with COVID-19 admitted to ICU: do markers tell the story? Dubai Med J 2021. DOI: 10.1159/000514406.
  17. Ahmeidi AA, Musa A, Ahmed HS, et al. Inflammatory markers as predictors of mortality in COVID-19 infection. Afr J Lab Med 2020;9(1):1298. DOI: 10.4102/ajlm.v9i1.1298.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.